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Abstract
Background: Young people often struggle to self-manage type 1 diabetes during the transition from childhood to adulthood.
Mobile health (mHealth) apps may have the potential to support self-management, but evidence is limited and randomized
controlled trials are needed.
Objective: We assessed whether the mHealth app “Young with Diabetes” improved young people’s self-management measured
by glycated hemoglobin (HbA1c) and three self-reported psychometric scales.
Methods: Young people (14-22 years) with inadequate glycemic control and their parents were enrolled in a randomized
controlled trial and assigned either to Young with Diabetes and usual care (Young with Diabetes group) or to usual care alone
(control). Young with Diabetes use was monitored; functions included a chat room, contact the health care provider, reminders,
tips, information about the diabetes department and type 1 diabetes topics, carbohydrate counting, and a parents’ section. Outcomes
included HbA1c and three self-reported psychometric scales: Perceived Competence in Diabetes Scale; Health Care Climate
Questionnaire; and Problem Areas In Diabetes care survey. Data were collected at baseline and at 2, 7, and 12 months.
Results: A total of 151 young people were randomized (Young with Diabetes group=76, control=75) and 49 parents agreed to
participate. At 12 months, HbA1c was significantly higher (4.1 mmol/mol; 0.4 %) in the Young with Diabetes group, compared
to the control group (P=.04); this finding did not occur when comparing app users (Young with Diabetes use ≥5 days) with
nonusers. Young people used Young with Diabetes on a mean of 10.5 days. They spent the most time chatting about alcohol and
searching for information about sex. Most young people and half of the parents reported that Young with Diabetes helped them.
More than 80% would recommend Young with Diabetes to peers.
Conclusions: Young with Diabetes did not improve HbA1c, but it may be a useful complement to self-management. Qualitative
evaluation is needed to explore benefits and shortcomings of Young with Diabetes. Health care providers should address young
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peoples’ knowledge about sensitive topics, provide them with peer support, and be aware of parents’ need for information about
how to support
Trial Registration: ClinicalTrials.gov NCT02632383; https://clinicaltrials.gov/ct2/show/NCT02632383 (Archived by WebCite
at http://www.webcitation.org/6zCK2u7xM)
(JMIR Mhealth Uhealth 2018;6(6):e141)   doi:10.2196/mhealth.9487
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Introduction
Background
As young people with type 1 diabetes (T1DM) grow up, they
are expected to assume responsibility for their disease
self-management [1]. This includes daily insulin dosage, glucose
measurements, and carbohydrate counting to meet the
recommended target for glycemic control [2]. However, young
people often struggle to achieve adequate glycemic control [3],
risking early onset of long-term complications [4]. Parents are
key players in supporting young people in self-managing T1DM,
but they are often faced with stress and frustration [5] and
request guidance on how to support their children [6].
Self-management is defined as an individual’s ability to manage
the symptoms and the consequences of living with a chronic
condition, including treatment, physical, social, and lifestyle
changes [7]. In young people, self-management is a gradual
process of acquiring necessary skills and knowledge, with
parents as consultants [1].
Mobile health (mHealth) apps present unique opportunities to
engage young people in self-management by providing
information and optimizing communication with health care
providers [8]. Recent studies among adults show promising
results. A systematic review assessed the effectiveness of
self-management apps in long-term conditions and found that
six of nine studies significantly improved outcomes [9]. Another
systematic review of 12 randomized controlled trials (RCTs)
demonstrated a significant reduction of glycated hemoglobin
(HbA1c) in adults (particularly with type 2 diabetes) allocated
to app-based interventions to support diabetes self-management
[10].
However, limited evidence exists that mHealth apps can improve
young peoples’ self-management [11]. Only three mHealth apps
for young people with T1DM have been evaluated. Frøisland
et al [12] tested a digital diabetes diary in a three-month
prospective cohort study. At a mandatory consultation, the diary
was discussed, and patients and providers reflected on its
recordings (n=12; ages 13-19). Berndt et al [13] tested an app
to collect data and provide clinical support in a four-week RCT
(n=68; ages 8-18). Finally, Goyal et al [14] tested an mHealth
app in a 12-month RCT (n=92; ages 12-15). The app facilitated
feedback on the transfer of blood glucose readings from a
glucometer, rewarding action. The three studies found no
improvement in HbA1c compared to the control group. However,
one study [14] found a statistically significant association
between increased self-monitored blood glucose and improved
HbA1c. Unfortunately, comparability is limited by the small
number of existing studies and differences in intervention
design. As the number of mHealth apps rapidly increases, a
pressing need arises for more RCTs to assess the impact of
mHealth apps among young people and their parents [15].
Young with Diabetes - The mHealth App
The mHealth app, Young with Diabetes (YWD), was developed
in 2014 and 2015 in a mixed-methods design based on a
participatory approach, with the aim of supporting young people
and parents in T1DM self-management. Usability was tested in
think-aloud tests and by a mail panel, and feasibility was tested
for five weeks by young people and health care providers. The
development is detailed elsewhere [16]. YWD is based on the
premise that providing a platform for young people to access
information and support from peers, parents, and health care
providers will improve their self-management skills. YWD
comprises eight main functions (Multimedia Appendix 1)
described in the following: (1) My Page enables users to contact
their health care provider and write notes, (2) My Department
provides information about the diabetes department, (3) Chat
Room is an opportunity to chat with peers, (4) Carbohydrate
Counting provides information on how to count carbohydrates,
(5) Information about… provides information about multiple
T1DM-topics, such as obtaining a drivers’ license, (6) Tips
Package enables users to receive daily T1DM tips, (7) To
Parents provides parents with information about how to support
their teen, and (8) Reminder Function allows users to set
reminders for self-management tasks.
The aim of this study was to test whether YWD improved
self-management, measured by HbA1c and three psychometric
scales, among young people with T1DM, compared with usual
outpatient care.
Methods
Design, Sample, and Setting
A 12-month, open, parallel RCT was conducted. Young people
were eligible for the study if they satisfied the following
conditions: (1) they had been diagnosed with T1DM for more
than one year, (2) received diabetes care at one of three pediatric
or three adult outpatient clinics (Multimedia Appendix 2), (3)
were 14 to 22 years of age, (4) had a HbA1c ≥64 mmol/mol (8%)
at their last visit and an average HbA1c>58 mmol/mol (7.5%)
at the last three visits prior to invitation, (5) did not attend
appointments with a psychiatrist or psychologist, (6) they spoke
and understood Danish, and (7) did not participate in other
diabetes intervention studies. Parents were invited to participate
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if their child was randomized to the YWD group and if they
spoke and understood Danish.
Recruitment Procedures
Young people and parents were recruited from November 2015
to March 2016. They received an invitation letter, followed by
a phone call to answer any questions. If young people were
interested, a one-hour meeting was scheduled to complete
written consents and randomization. Participants were digitally
randomized in a 1:1 allocation ratio either to YWD and usual
care (YWD group) or usual care alone (control). They were
stratified by department in random permuted blocks of two and
four. Blinding was not possible.
Intervention
After randomization, young people and parents downloaded
YWD on their smartphone or tablet during a 10-minute initial
face-to-face or telephone guidance session provided by the first
author. The parents received the same version of YWD except
for the Chat Room, which was only available for young people.
Young people were encouraged to use YWD as a stand-alone
resource and in collaboration with their parents and health care
providers. They received no prompts to use YWD. The control
group received only usual outpatient care, which consisted of
quarterly clinic visits (measuring HbA1c, adjusting insulin and
receiving guidance on carbohydrate counting).
Physicians, nurses, and dieticians provided the YWD
intervention as part of usual outpatient care and saw participants
from both the YWD and control groups. No extra time was
allocated for the YWD intervention. Health care providers
attended YWD training: a one-hour introduction to the app
followed by two roleplaying scenarios with a colleague or the
first author acting as young patients [16].
The first author offered monthly visits to health care providers
to address technical issues and refresh training in app use; a
telephone hotline was available for technical difficulties. The
app content did not change during the study.
Outcome Measures
Outcomes data were collected at baseline and two months, seven
months, and 12 months after YWD use began. The primary
outcome of HbA1c was measured by a single automated
glycohemoglobin analyzer (Tosoh) at Nordsjællands Hospital.
Three psychometric self-reported scales measured the secondary
outcome of the development of self-management skills.
Perceived competence at managing diabetes was measured by
the five-item Perceived Competence in Diabetes Scale (PCD)
[17]. The degree to which participants experienced their health
care provider to be autonomy-supportive in providing general
treatment was measured using the five-item Health Care Climate
Questionnaire (HCCQ) [17]. The perceived burden of
diabetes-related problems was assessed using the 20-item
Problem Areas in Diabetes care survey (PAID-20) [18]. Severe
hypoglycemic episodes (low blood glucose levels requiring
assistance from another person) and acute diabetes-related
hospitalizations were self-reported.
Sociodemographic Items and Young with
Diabetes-Specific Questions
Sociodemographic characteristics (gender, age, height, weight,
age at diabetes onset, occupation, family structure, comorbidity,
insulin regime, weekly blood glucose measurements, transfer
to adult care, smoking, and alcohol use) were self-reported.
Responses to YWD-specific questions, such as “Has YWD
helped you?” and “Would you recommend it to peers?” were
self-reported using yes/no response options.
The psychometric scales, sociodemographic items, and
YWD-specific questions were compiled into an electronic
questionnaire. Face validity was tested in six young people
before the trial start; no changes were required.
YWD users were defined as those who had used YWD on at
least five days. The cutoff of five days was set to be sure the
participants used the app more than the four times where they
were paid a visit from the data collector (baseline, 2, 7, and 12
months). YWD use was documented by log data as time, date,
and action (view, update, create, delete). Page hits were defined
as the number of “clicks” within a function. Technical issues
were noted.
Power Estimation
Sample size estimation was based on HbA1c. A minimum of 52
participants per group was necessary to detect a difference of
5.5 mmol/mol (0.5 %) in HbA1c at 80% power with 5%
significance level, a standard deviation in the outcome variable
of 0.5, and a 2-tailed significance test. To compensate for
potential dropouts, a 25% adjustment was made, resulting in a
target sample size of 65 subjects per group.
Statistical Analysis
Baseline data were described by mean and standard deviation
(continuous variables) and frequencies and proportions
(categorical variables). In accordance with the CONSORT
guidelines [19], hypothesis tests for baseline differences were
not performed.
The primary intention-to-treat analysis, comparing groups at
12 months, was performed by a linear regression model adjusting
for baseline values and diabetes department. Due to stratified
randomization, the department was included in the regression
model as a categorical covariate [20].
The effect of YWD depends on use. Consequently, the
CONSORT-EHEALTH checklist [21] recommends a sub-group
analysis comparing users with nonusers, equivalent to an
as-treated analysis. YWD use is a post-randomization variable,
and the possibility that several unmeasured factors affected both
the probability of noncompliance with the intervention and
glycemic control confounds the as-treated analysis. We,
therefore, focused on estimating the complier average causal
effect of YWD [22]. The analysis compared the effect of the
intervention among compliers (the observed YWD users and
those from the control group who would have been YWD users
had they been assigned to the YWD group) and non-compliers
(the observed YWD non-users and those from the control group
who would have used YWD less than 5 days had they been
assigned to the YWD group) [22]. The causal effect of YWD
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on HbA1c at 12 months among compliers was estimated by the
expectation-maximization algorithm assuming normally
distributed outcomes in each of the principal strata under
one-sided noncompliance. This estimate was adjusted for
baseline HbA1c and department. Baseline variables were
included as covariates for the probability of compliance with
the treatment allocation in a latent logistic regression model.
Secondary analyses of outcomes (HbA1c, PCD, HCCQ and
PAID) over time were performed using a constrained mixed
model incorporating all measurement periods [23]. Confidence
intervals were calculated using normal approximation. The
number of acute hospitalizations and severe hypoglycemic
episodes was compared by logistic regression after
dichotomizing outcomes into zero or one or more events.
Analyses were performed by a statistician blinded to group
assignment using R version 3.3.3 and Mplus7. A value of P
≤.05 was considered to be statistically significant.
Ethical Considerations
YWD complies with regulations for protecting personal health
information. A code was required to access YWD in addition
to user name and password. Written informed consent was
obtained from young people and parents, and parental consent
was required for participants younger than 18 years. The study
was approved by the Danish Data Protection Agency (no. 04015
NOH-2015-031) and performed in accordance with ethical
recommendations of Helsinki Declaration. Ethical approval by
Research Ethics Committee was not necessary (Ref.no.
14013934). The study is registered at ClinicalTrials.gov
(NCT02632383). The RCT is reported in accordance with the
CONSORT-EHEALTH guidelines for improving and
standardizing evaluation reports of Web-based and mobile health
interventions (Multimedia Appendix 3 shows the
CONSORT-EHEALTH checklist [21])
Results
Overview
A total of 852 young people were assessed for eligibility, of
whom 701 were excluded (Figure 1). In total, 126 young people
declined to participate because they were too busy (n=64), were
not interested in the research project (n=29), did not want to
focus on diabetes (n=11), did not feel they needed the app
(n=10), had no reason (n=9), or due to illness (n=3). A total of
151 young people (54% female) were randomized to the YWD
group (n=76) or control group (n=75); of these, 148 (YWD=75,
control=73) completed follow-up assessments, yielding a
retention rate of 98%.
Participants were enrolled at their homes (n=121), school (n=10),
hospital (n=9), café (n=4) or by phone (n=7).
Baseline Characteristics
Participants’ mean age was 17.6 (SD 2.6) years, and their mean
duration of T1DM was 8.0 (SD 4.5) years (Table 1). One third
(n=42, 28%) had at least one comorbidity, and half (n=70, 46%)
of the participants’ parents were divorced. A total of 49 parents
participated, representing 40 (53%) young people in the YWD
group.
Outcome Measures
Glycated Hemoglobin
Mean baseline HbA1c (Figure 2 and Table 2) was 81.1 mmol/mol
(SD 18.0) or 9.6% (SD 1.6) in the YWD group and 76.2
mmol/mol (SD 14.9) or 9.1% (SD 1.4) in the control group.
This difference was not significant (P=.07). At the 12-month
follow-up, mean HbA1c was 81.4 mmol/mol (SD 18.8) or 9.6%
(SD 1.7) in the YWD group and 73.9 mmol/mol (SD 12.6) or
8.9% (SD 1.2) in the control group. The
intention-to-treat-analysis, comparing the two groups at 12
months, showed a significant difference in glycemic control
(P=.04), with the control group having a 4.1 mmol/mol (95%
CI 0.3-7.9) or 0.4% (95% CI 0.0-0.7) lower mean HbA1c after
adjusting for baseline values. After including all follow-up
periods in the mixed model, this difference was 4.3 mmol/mol
(95% CI 0.7-8.0) or 0.4% (95% CI 0.1-0.7, P=.02). Despite
randomization, the YWD group included more females. This
difference was not significant (P=.37); adjusting for gender in
the intention-to-treat analysis did not change the results.
Effect of App Use on Glycated Hemoglobin
The as-treated analysis, comparing YWD users with nonusers,
yielded a non-significant difference in HbA1c at 12 months
(P=.67), with the control group having a 0.9 mmol/mol (95%
CI –3.1 to 4.9) or 0.1% (95% CI –0.3 to 0.4) lower mean HbA1c.
The complier average causal effect of YWD, comparing the
effect of the intervention among compliers and non-compliers
(please refer to the Statistical Analysis section for further
details), yielded a non-significant difference of 3.9 mmol/mol
(95% CI –0.7 to 8.9) or 0.4% (95% CI –0.1 to 0.8, P=.11) in
HbA1c, favoring the control group. No baseline covariates were
significantly associated with the probability of compliance with
the treatment allocation (Multimedia Appendix 4). However, a
negative effect on the probability of compliance to the treatment
allocation was related to comorbidity, divorced parents, severe
hypoglycemic episodes during the previous 12 months,
forgetting insulin, smoking, alcohol-drinking intake and skipping
school. A positive effect on the probability of compliance with
the treatment allocation was related to the number of glucose
measurements last week, acute hospitalizations, insulin pump
and the female gender.
Self-Reported Self-Management of Type 1 Diabetes
As shown in Table 2, no significant effects on PCD (P=.39),
PAID (P=.13), or HCCQ (P=.53) were observed.
Hypoglycemia and Hospitalizations
Between-group differences in acute diabetes-related
hospitalizations and severe hypoglycemia were not statistically
significant. Seventeen (22%) participants from the YWD group
and 8 (11%) participants from the control group were
hospitalized for an acute event at least once during the 12-month
study period. The control group had 54% lower odds (odds ratio
[OR] 0.46, 95% CI 0.17-1.15, P=.10) of acute hospitalization
after adjusting for acute hospitalizations during the 12 months
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prior to enrollment. A total of 34 (45%) participants in the YWD
group and 29 (39%) in the control group experienced at least
one episode of severe hypoglycemia. The control group had
13% lower odds (OR 0.87, 95% CI 0.43-1.75, P=.70) of severe
hypoglycemia, compared to YWD group, after adjusting for
hypoglycemic episodes during the year prior to the study.
Figure 1. Participant flow diagram.
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Table 1. Sample characteristics.
Control (n=75)YWDa (n=76)Characteristics
37 (49)44 (58)Female, n (%)
17.6 (2.7)17.6 (2.6)Age in years, mean (SD)
9.9 (4.9)9.2 (4.3)Age at diabetes onset in years, mean (SD)
7.7 (4.7)8.3 (4.3)Diabetes duration in years, mean (SD)
76.2 (14.9)81.1 (18.0)Baseline HbA1c
b (mmol/mol), mean (SD)
27.5 (6.2)27.4 (6.0)Baseline PCDc score, mean (SD)
24.0 (16.1)26.7 (19.3)Baseline PAIDd score, mean (SD)
25.4 (8.4)28.2 (6.8)Baseline HCCQe score, mean (SD)
13 (17)19 (25)≥1 acute diabetes-related hospital admissionf, n (%)
23 (31)27 (36)≥1 episodes of severe hypoglycemia, n (%)
25.8 (15.5)24.4 (12.8)SMBGg per week, mean (SD)
Forget to take insulin, n (%)
10 (13)5 (7)Every day
24 (32)24 (32)One to four times a week
22 (29)25 (33)One or more times a month
19 (25)22 (29)Never or almost never
23.3 (3.4)22.1 (3.2)BMIh, kg/m2, mean (SD)
25 (33)23 (30)Smoking cigarettes ≥1 time in the last month, n (%)
50 (67)50 (66)Drinking alcohol ≥1 time in the last month, n (%)
Insulin regimen, n (%)
40 (53)40 (53)Multiple daily injections of insulin
35 (47)36 (47)Pump
32 (43)34 (45)Living with both parents, n (%)
32 (43)38 (50)Divorced parents, n (%)
Education, n (%)
26 (35)28 (37)Danish public school (grade 0-10)
2 (3)2 (3)Continuation school
14 (19)15 (20)Secondary educationi
7 (9)6 (8)University
10 (13)12 (16)Other schoolsj
16 (21)13 (17)Not attending a school at the moment
Pediatric site, n (%)
13 (17)12 (16)Pediatric and Adolescent Department, Nordsjællands Hospital, Hillerød
26 (35)26 (34)Pediatric and Adolescent Department, Herlev
7 (9)7 (9)Pediatric Department, Roskilde
Adult site, n (%)
6 (8)6 (8)Department of Cardiology, Nephrology and Endocrinology, Nordsjællands Hospital, Hillerød
20 (27)20 (26)Steno Diabetes Center
3 (4)5 (7)Department of Endocrinology, Køge
5 (7)7 (9)Transfer to adult care, n (%)
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Control (n=75)YWDa (n=76)Characteristics
20 (27)22 (29)Comorbidity, n (%)
2 (3)6 (8)Learning disability and/or mental health condition
aYWD: Young with Diabetes.
bHbA1c: glycated hemoglobin.
cPCD: Perceived Competence in Diabetes Scale.
dPAID: Problem Areas in Diabetes Scale.
eHCCQ: Health Care Climate Questionnaire.
fAcute hospital admission caused by hyperglycemia, ketoacidosis or hypoglycemia.
gSMBG: self-monitored blood glucose.
hBMI: body mass index.
iSecondary education: Gymnasium, Higher Preparatory Examination, Higher Commercial Examination Program, Higher Technical Examination Program.
jOther schools, such as taking a bachelor in nursing or attending a school of crafts.
Figure 2. Mean glycated hemoglobin (HbA1c) levels in control and Young with Diabetes (YWD) groups at 2, 7, and 12 months.
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Table 2. Between-group differences in outcomes.
P valueb
Control versus YWDa, mean difference (95% CI)Adjusted mean at baselineOutcome
12 months7 months2 months
0.02–4.3 (–8.0 to 0.7)–6.2 (–9.5 to –2.9)–2.8 (–5.4 to –0.3)78.9HbA1c
c, mmol/mol
0.02–0.4 (–0.7 to 0.1)–0.6 (–0.9 to –0.3)–0.3 (–0.5 to 0.0)9.4HbA1c
c, %
0.39–0.79 (–2.56 to 0.98)–0.53 (–2.55 to 1.50)0.27 (–1.50 to 2.03)28.18PCDd scoree
0.13–3.14 (–7.22 to 0.95)0.96 (–3.00 to 4.91)–2.64 (–6.17 to 0.88)23.68PAIDf scoree
0.53–0.73 (–2.98 to 1.52)0.04 (–2.52 to 2.61)–0.05 (–2.44 to 2.35)27.10HCCQg scoree
aYWD: Young with Diabetes.
bSignificance level of difference at 12 months follow-up.
cHbA1c: glycated hemoglobin.
dPCD: Perceived Competence in Diabetes Scale.
eRange for PCD and HCCQ is 5-35 and the range for PAID is 0-100.
fPAID: Problem Areas in Diabetes.
gHCCQ: Health Care Climate Questionnaire.
Young with Diabetes-Specific Questions
Fifty-nine (78%) young people and 25 (51%) parents reported
that YWD had helped them at least once. Most young people
(n=65, 85%) and parents (n=41, 84%) reported that they would
recommend YWD to peers.
Young with Diabetes Use
Young people used YWD on a mean of 10.5 days (range 1-64),
while parents used YWD on a mean of 5 days (range 1-21). A
total of 53 (70%) young people and 19 (39%) parents used YWD
on at least 5 days, while 7 (9%) young people and 13 (27%)
parents never used YWD after the introductory session. Figure
3 depicts weekly YWD activity.
In total, 71 messages were sent to 14 (36%) health care providers
by 15 (20%) young people. The messages were primarily used
to schedule visits (n=25), ask treatment questions such as about
insulin dose (n=24); discuss challenges such as eating disorders
and feeling alone (n=9); and provide ongoing support such as
feedback on glucose measurements (n=13).
A total of 103 chat-room comments were posted by 28 (37%)
young people (Multimedia Appendix 5). The majority of chat
time was spent on Alcohol, Sport, and Fuck Diabetes. Fifteen
(20%) young people created reminders, and 46 (61%) activated
tips packages. The carbohydrate-counting quiz was initiated 68
times by 46 (61%) young people. Only 7 (9%) young people
watched animations, while 18 (24%) clicked on video
self-portraits. The most popular main functions were Chat Room
and My Page (Multimedia Appendix 6), and the most popular
information topics were Sex, What is Diabetes?, Driver’s
License, and Alcohol and Party (Multimedia Appendix 7).
Among parents, the most popular main functions were
Information about … and To Parents (Multimedia Appendix
6). Parents primarily approached How to Support My Teen,
When My Teen turns 18, Alcohol and Party, and Being Young
with Diabetes (Multimedia Appendix 7).
Technical Issues
Four major platform-specific technical issues occurred and were
resolved: (1) January 2016, Android. Starting
carbohydrate-counting-quiz resulted in log-off (duration=10
days, n=1), (2) March 2016, iOS. YWD could not open on some
iPhone-software versions. Required re-installation (duration=10
days, n=7), (3) September 2016, Android. Unable to upload
photos (duration=40 days, n=1), and (4) January 2017, iOS.
YWD could not open due to update. Needed re-installation
(duration=10 days, n=14). In addition, participants reported
minor technical issues, such as having lost the YWD app due
to new or broken phones (young people=26, parents= 2). A total
of 43 (57%) young people and eight (16%) parents reported
technical issues.
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Figure 3. Number of young people who used Young with Diabetes (YWD) during the study.
Discussion
Principal Findings
To the best of our knowledge, this is the largest RCT to date
evaluating the effect of an mHealth app supporting
self-management in young people with T1DM and their parents.
YWD did not improve glycemic control, and the app use
declined rapidly. Interestingly, most of the participants reported
that YWD was helpful and that they would recommend it to
others.
We can only speculate as to why HbA1c did not improve in the
YWD group. A large difference was observed between the
results from the as-treated analysis and the estimate of the
complier average causal effect (0.9 mmol/mol vs. 3.9 mmol/mol,
respectively). This may indicate the existence of unmeasured
confounding variables influencing HbA1c and YWD use. Health
care providers play a significant role in supporting young people
to self-manage [24]. However, not all health care providers feel
confident using mHealth apps [25], and some may feel
uncomfortable engaging with young people through technical
means [26,27]. This could have influenced the effect of YWD.
Unfortunately, we neither registered the young people’s health
care provider nor stratified at the level of the health care
provider. Also, YWD training for health care providers was
very brief; further training may optimize health care providers’
ability to use YWD as a platform for collaborating with young
people and parents. Furthermore, the use of YWD declined
rapidly during the RCT (Figure 3), which may be one of the
main reasons why the intervention lacked improvement of
self-management. Since the participants did not use YWD for
long, a mediation analysis would have been highly relevant.
However, the study was an RCT designed and powered for
assessing the difference in HbA1c and therefore, we did not
pursue a post-hoc analysis. This is important to address in the
design of future studies.
A qualitative study by Klasnja et al [28] found that most people
diagnosed with diabetes, face acute need for information about
their disease and that this need becomes more intermittent
afterwards. It would have been highly relevant to test YWD in
a group of people newly diagnosed with T1DM. Unfortunately,
HbA1c differs and changes a lot during the time around diagnosis
depending on how long (days, weeks, or months) people have
had diabetes before it is diagnosed and depending on the degree
of the eventual honeymoon phase. Since HbA1c was our primary
outcome, we had to be sure that we only included patients with
“stable” diabetes to better identify the effect of the intervention.
This challenge could be addressed in future studies by qualitative
evaluation of self-management apps in people just diagnosed
with diabetes.
We were unable to measure participants’ eHealth skills, which
may have influenced YWD use and subsequent HbA1c levels
since it is related to improved outcomes [29-31]. Furthermore,
baseline HbA1c was higher in the YWD group, which may
indicate poor motivation and lack of self-management skills,
which would affect the ability to use YWD and improve
HbA1c[32]. Finally, it is arguable whether a randomized trial is
the optimal way to evaluate YWD. Diabetes care should be
individualized [33], and mHealth apps, which evolve and are
updated over time, are often incompatible with a rigid RCT
study design. Furthermore, Campbell et al [34] raise doubts
about RCTs as an evaluation method targeting young people in
transition from childhood to adulthood due to the complex,
patient-centered, evolving, and multidisciplinary nature of care.
Alternative methods may be preferable, such as qualitative
evaluations and interrupted time series [35].
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Further qualitative evaluation [36] is needed to understand why
most young people reported being helped by using YWD,
despite failing to improve glycemic control and maintain app
use. Also, successful adoption of self-management apps is hard
to achieve without additional strategies for enhancing patient
motivation and engaging health care providers [37]. Finally,
simply knowing how often and how much young people engage
with YWD by opening the app and clicking around may not be
enough. Understanding and observing “effective engagement”
[38,39] with mHealth apps is much harder to do, and better
ways need to be worked out. This should be taken into account
in future studies.
Notably, the most popular app function among young people
was the Chat room, where they shared experiences. The most
popular topics were Alcohol and Fuck Diabetes. While few
participants posted comments, most read about others’
experiences. This is consistent with previous findings [40,41]
and underscores the importance of online peer support to
complement education and provide reassurance that lived
experiences are common [42].
In contrast, more sensitive topics, such as sex, were not
discussed in the chat room but were the most popular topic
searched privately. Wiley et al [42] explored young adults’
experiences with T1DM education and found that health care
providers did not address sensitive topics such as sex. Our
findings and those of Wiley et al highlight the unmet needs of
young people and parents, which should be solicited and
addressed regularly in clinic visits. They underscore the
importance of acknowledging young peoples’ need for sharing
experiences with peers and providing them with opportunities
to engage with peer networks. The findings also emphasize
parents’ need for guidance in supporting their child and the
importance of addressing sensitive topics regularly.
Strengths and Limitations
Our study has several strengths. A rigorous design tested YWD
in an RCT over a lengthy study period, and YWD use was
logged and available for analysis. Our study had both a large
sample size and a high retention rate. The high retention rate
could be a result of the flexibility to collect data at young
peoples’ choice of place and time of day and should be
considered a way to ensure high retention rates in future studies
with young people.
Limitations should also be considered. It was not possible to
conduct a blinded RCT [43,44]. Not all young people had
participating parents. No clear criteria were defined for how
health care providers should deliver YWD. Also, we cannot
exclude the possibility of a spillover effect because the same
health care professionals provided both the YWD intervention
and usual care. Finally, a concern is whether HbA1c and the
three psychometric questionnaires (PCD, HCCQ, PAID-20)
captured changes in self-management as intended. Our choice
of scales was limited by lack of validated self-management
instruments in Danish and also by the ages of the participants,
spanning below and above 18 years. The outcomes were chosen
based on the self-management definition [1,7] and because they
have been used in similar populations testing self-management
interventions [45,46], increasing the comparability of our study.
Conclusion
The mHealth app YWD did not improve HbA1c, but it may be
a useful tool for complementing self-management in young
people with T1DM. Qualitative evaluation is needed to further
explore and address benefits and shortcomings of the
intervention [36]. Alternative evaluation methods should be
considered when testing self-management mHealth apps among
young people. Our findings highlight the importance of
supplementing self-management care with peer support. Health
care providers should routinely address sensitive topics and be
aware of parents’ need for guidance as to how to effectively
support their child during the transition from childhood to
adulthood.
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